BioSpace News Archive

SyntheticMR announced today that their quantitative imaging software solution SyMRi has received regulatory approval in Japan and can now be sold on this market.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced that George Yeh, President of TLC, will be presenting the latest updates on the company in a fireside chat with Madhu Kumar, Senior Research Analyst, at Baird’s 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 8:30am ET.

Innovent Biologics, Inc. announced that SULINNO®, a recombinant human anti-TNF-α monoclonal antibody drug, has been officially approved by the National Medical Products Administration of China for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriasis in China.

Fulgent Genetics, Inc., a technology company providing comprehensive testing solutions through its scalable technology platform, announced that beginning September 28th, all patients tested for COVID-19 by Fulgent Genetics will also receive results for Influenzas A and B.

Nemaura Medical, Inc. announced that its CEO Dr. Faz Chowdhury will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 10:20 a.m. ET.

Karuna Therapeutics, Inc. announced that senior management will participate in the following upcoming virtual investor conferences

Reported Positive Topline Pre-Specified Interim Results from PROTECTIVE-2 (Study 106) Phase 3, Demonstrating Plinabulin’s Superiority in Combination with Neulasta for CIN Prevention vs. Neulasta Alone

Sol-Gel Technologies, Ltd. announced that Bausch Health Companies, Inc. initiated patent infringement action in the U.S. District Court for the District of New Jersey on August 31, 2020 with regards to Perrigo Company plc Abbreviated New Drug Application for a generic version of Duobrii® lotion, for the treatment of plaque psoriasis in adults

Plus Therapeutics, Inc., announced that it has been invited to present at the 9th Annual Gateway Conference, which is being held virtually on September 9-10, 2020.

Avanos Medical, Inc. announced the publication of a large, randomized, multicentered clinical trial comparing the safety and efficacy of COOLIEF* Cooled Radiofrequency ablation to hyaluronic acid injection for the management of chronic knee pain caused by osteoarthritis.